首頁 > 市場調查報告書 > 材料

市場調查報告書

商品編碼

1479836

多不飽和脂肪酸市場－2024年至2029年預測

Polyunsaturated Fatty Acids Market - Forecasts from 2024 to 2029

出版日期: 2024年04月11日 | 出版商:

Knowledge Sourcing Intelligence | 英文 143 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

多不飽和脂肪酸市場預計將以 8.13% 的複合年成長率成長，市場估值將從 2022 年的 107.17 億美元增至 2029 年的 185.27 億美元。

多效價脂肪是膳食脂肪的一種，與單元不飽和脂肪一起被歸類為有益脂肪。這種類型的脂肪存在於植物和動物來源中，例如鮭魚、植物油以及精選的堅果和種子。攝取適量的多不飽和脂肪酸（以及單元不飽和脂肪酸）而不是飽和脂肪酸和反式脂肪酸有助於整體健康。

多不飽和脂肪酸包括稱為Omega-3和Omega-6脂肪酸的必需脂肪酸。 Omega-3和Omega-6脂肪酸在支持大腦功能和細胞生長方面發揮著重要作用。人體不能產生必需脂肪酸，因此必須從食品中獲取它們。多不飽和脂肪酸的工業包括食品、營養補充、藥品和飼料。

多不飽和脂肪酸分為Omega-3和omega-6脂肪酸。這種差異反映了這些脂肪酸在促進健康方面所發揮的不同作用。此外，多不飽和脂肪酸市場按形式細分，為消費者提供多樣化的選擇。有錠劑、液體、軟膠囊和粉末可供選擇，每種都能滿足各種偏好且易於食用。多不飽和脂肪酸的這種多效性因其營養價值和在各行業的多樣化應用而變得有用。

市場促進因素

老年人口意識不斷增強

多不飽和脂肪酸(PUFA) 對於維持最佳健康至關重要，尤其是老年族群。在PUFA中， Omega-3脂肪酸如DHA在維持大腦健康方面發揮重要作用。研究表明，這些脂肪酸可能有助於維持認知功能、降低失智症風險並改善老年人的記憶力。

此外，PUFA，特別是Omega-3脂肪酸，具有發炎特性，有助於管理各種健康狀況，並有助於整體健康。人口老化趨勢明顯，統計數據顯示，老年人口數量顯著增加。到 2020 年，美國大約有六分之一的人年齡在 65 歲以上，這與 1920 年的人口結構形成鮮明對比，當時這個年齡層的人口比例不到二十分之一。

這種全球老化現像在日本等國家也很明顯，日本是世界上人口老化程度最高的國家。目前，日本超過十分之一的人年齡超過80歲，處於老化浪潮的最前線。

不斷變化的年齡特徵強調需要解決與老齡化相關的健康問題的解決方案，從而導致對多元不飽和脂肪酸等補充品的需求增加。

慢性病增加

心血管疾病、糖尿病和神經退化性疾病等慢性疾病的全球盛行率正在穩步上升，需要營養補充食品控制這些症狀並改善整體健康。 CDC 報告稱，美國十分之六的成年人至少患有一種慢性病，十分之四的人患有兩種或兩種以上慢性病。 2021年，美國糖尿病協會透露，有3,840萬美國人被診斷出患有糖尿病，佔總人口的11.6%。同樣，世界衛生組織（WHO）指出，在印度，18歲以上的人有7,700萬患有第2型糖尿病。這些令人震驚的數字凸顯了迫切需要採取干涉措施來促進健康和對抗慢性病的傳播。

為了應對這一日益嚴重的健康危機，對富含健康促進成分的機能性食品、食品和飲料的需求正在迅速增加。多元不飽和脂肪酸正在成為這一趨勢的關鍵參與者，並應用於多種產品，包括強化乳類飲料、塗抹醬、烘焙點心和嬰兒奶粉。

市場限制因素

價格波動

多不飽和脂肪酸來自海洋來源，例如魚油和精選農產品，並且會根據氣候條件和供應鏈內的其他不確定因素而受到價格波動的影響。這些波動給生產和購買 PUFA 的製造商和消費者都帶來了挑戰。由於 PUFA 對外部因素很敏感，因此行業內需要採取適應策略，以使製造商和消費者都能以實惠的價格獲得 PUFA。

多不飽和脂肪酸市場按類型細分： Omega-3和 Omega-6。

在PUFA市場中，按類型細分主要包括兩大類： Omega-3和Omega-6。 Omega-3脂肪酸已被證明可以透過有效降低壞膽固醇 (LDL) 同時提高好膽固醇 (HDL) 來降低心臟病和中風的風險。因此，對富含Omega-3 的機能性食品和飲料的需求不斷增加。另一方面，Omega-6 存在於更廣泛的食品來源中，因此更容易融入您的日常飲食中。 Omega-6脂肪酸在各種食品中的多功能性使其易於整合。

預計北美將佔據多不飽和脂肪酸市場的主要佔有率。

北美將在 PUFA 市場中佔據顯著地位，有幾個影響因素促成了這一點。一個重要因素是大眾對多元不飽和脂肪酸的健康益處的認知不斷提高。這種日益成長的意識正在推動對富含 PUFA 的食品、飲料和補充品的強勁需求。

北美在 PUFA 市場佔據主導地位的一個主要因素是其強勁的經濟，其特點是與許多其他地區相比可支配收入較高。世界銀行報告顯示，截至2021年，美國最終消費支出為19.26兆美元。這種經濟力量使消費者能夠將更多資源分配到含有多元不飽和脂肪酸的健康和保健產品。意識的提高和強勁的經濟狀況相結合，凸顯了北美在塑造 PUFA 市場方面的重要作用。

公司產品

Ultra Omega-3 /6/9(TM) 軟膠囊 - NaturesPlus 提供 Ultra Omega-3 /6/9(TM) 軟膠囊，這是一種食品配製的營養補充，可提供必需不飽和脂肪酸的最佳比例。此補充品由最優質的非基因改造成分製成，包括琉璃苣油、魚油和助焊劑，可促進心臟健康，保持骨骼強健，滋養皮膚活力，支持認知功能，旨在支持您的整體健康。
MARNYS(R) Omega-MARNYS(R) Omega 3+6 Junior 是一種有價值的食品補充品，它利用了從琉璃苣和助焊劑中提取的必需植物性歐米茄油的功效。琉璃苣提供的 omega-6 脂肪酸含量超過 20%，亞麻籽提供的Omega-3含量超過 55% α-亞麻酸。這種獨特的組合可支持正常的心血管和胃腸功能，並在維持健康的免疫系統方面發揮重要作用。
Momentous 推出 Omega-3-Momentous 提供富含必需脂肪酸的Omega-3補充品，尤其是從魚油中提取的 EPA 和 DHA。我們建議每天隨餐服用兩粒軟膠囊。將這種補充品納入您的日常生活可以有助於實現您的營養目標。

Polyunsaturated fat, a variant of dietary fat, is classified among the beneficial fats alongside monounsaturated fat. This type of fat is present in both plant and animal sources, including salmon, vegetable oils, and select nuts and seeds. Moderate consumption of polyunsaturated (as well as monounsaturated) fats instead of saturated and trans fats can contribute to overall health.

Polyunsaturated fats include essential fatty acids known as omega-3 and omega-6 fats. These play a crucial role in supporting brain function and cell growth. Since our bodies do not produce essential fatty acids, obtaining them from food sources is imperative. The industry applications of polyunsaturated fatty acids include food, nutraceuticals, pharmaceuticals, and feed applications.

Polyunsaturated fatty acids are categorized by type, with distinctions made between Omega-3 and Omega-6. This differentiation reflects the diverse roles these fatty acids play in promoting health. Furthermore, the polyunsaturated fatty acids market is segmented by form, offering diverse options for consumers. These include tablets, liquids, soft gels, and powders, each catering to varied preferences and ease of consumption. This multifaceted nature of polyunsaturated fats makes them useful for their nutritional significance and their diverse applications in different industries.

Market Drivers

Rising awareness in the geriatric population

Polyunsaturated fatty acids (PUFAs) are crucial for maintaining optimal health, particularly in the geriatric population. Among PUFAs, omega-3s, such as DHA, play a vital role in supporting brain health. Research suggests that these fatty acids contribute to preserving cognitive function, lowering the risk of dementia, and potentially improving memory in older adults.

Furthermore, PUFAs, especially omega-3s, exhibit anti-inflammatory properties that can help manage various health conditions and contribute to overall well-being. The demographic shift towards an aging population is evident, with statistics indicating a notable increase in the elderly population. In 2020, approximately 1 in 6 individuals in the United States were aged 65 and above, in stark contrast to the demographic composition in 1920, where this age group comprised less than 1 in 20 of the population.

This global aging phenomenon in countries like Japan is known for having the world's oldest population. In Japan, more than 1 in 10 individuals are now aged 80 or older, placing the country at the forefront of the ageing demographic wave.

The evolving age structure underscores the need for solutions that address health concerns associated with aging, leading to an increased demand for supplements such as PUFAs.

Rising prevalence of chronic diseases

The global incidence of chronic diseases, including cardiovascular ailments, diabetes, and neurodegenerative disorders, is steadily increasing, demanding dietary supplements to manage these conditions and enhance overall health outcomes. Statistics highlight the severity of this health challenge, with 6 out of 10 adults in the United States affected by at least one chronic disease, and 4 out of 10 having two or more, as reported by the CDC. In 2021, the American Diabetes Association revealed that 38.4 million Americans, constituting 11.6% of the population, were diagnosed with diabetes. Similarly, the World Health Organization notes that in India, a staggering 77 million individuals above the age of 18 are grappling with type 2 diabetes. These alarming figures underscore the urgent need for interventions that promote health and combat the rising prevalence of chronic diseases.

In response to this growing health crisis, there is a surging demand for functional foods and beverages enriched with health-promoting ingredients. PUFAs are emerging as a key player in this trend, finding applications in various products such as fortified dairy drinks, spreads, baked goods, and infant formula.

Market Restraints

Price volatility

Polyunsaturated fatty acids, derived from marine sources such as fish oil and select agricultural sources, are susceptible to price fluctuations influenced by climate conditions and other uncertainties within the supply chain. These variations pose challenges for both manufacturers and consumers in producing and purchasing PUFAs. The sensitivity of PUFAs to external factors underscores the need for adaptive strategies within the industry to make them affordable for both manufacturers and consumers.

The polyunsaturated fatty acids market is segmented by type, with omega-3 and omega-6.

Within the PUFA market, segmentation by type primarily comprises two main categories: omega-3 and omega-6. Omega-3 fatty acids are recognized for their potential to reduce the risk of heart disease and stroke by effectively lowering bad cholesterol (LDL) while simultaneously elevating good cholesterol (HDL). This has fueled a growing demand for functional foods and beverages enriched with omega-3s. On the other hand, omega-6 is found in a broader spectrum of food sources, rendering them more accessible for incorporation into the daily diet. The versatility of omega-6 fatty acids in various foods enhances their ease of integration.

North America is anticipated to hold a significant share of the polyunsaturated fatty acids market.

North America will hold a notable position in the PUFA market, by several influential factors contribute to this position. One key factor is the heightened general awareness of the health benefits associated with PUFAs. This increased awareness acts as a driving force, generating a robust demand for PUFA-enriched foods, beverages, and supplements within the region.

A significant contributor to North America's dominance in the PUFA market is its robust economy, characterized by higher disposable incomes compared to many other regions. As of 2021, the United States recorded a final consumption expenditure of 19.26 trillion current US dollars, as reported by the World Bank. This economic strength empowers consumers to allocate more resources toward health and wellness products, including those containing PUFAs. The combination of heightened awareness and a strong economic landscape underscores North America's important role in shaping the PUFA market.

Market developments

October 2023 - Dsm-Firmenich announced the launch of life's(R)omega o3020, marking a milestone as the first and only single-source algal omega-3 with an EPA/DHA ratio identical to that naturally found in fish oil. Life's(R)omega o3020 presented a notable ratio of 1.5:1 EPA (eicosapentaenoic acid) to DHA (docosahexaenoic acid); this is twice the potency. The launch represented a significant advancement in providing consumers with a potent and sustainable algal omega-3 option, aligning with evolving preferences and industry trends.
April 2023 - The leading biotech company, Mialgae, successfully launched its omega-3 product, Naturalgae, to the market following the recent expansion of its commercial production site in Scotland. Mialgae pioneered a sustainable approach by recycling co-products from the scotch whisky industry, such as pot ale, to cultivate omega-3-rich microalgae. These microalgae serve as an excellent source for producing nutritious fish feed and pet food ingredients.
March 2022 - Polaris, a prominent leader in fatty acids characterized by high concentrations of EPA and DHA, announced a successful fundraising round of €5 million, spearheaded by Seventure partners through its Health for Life capital(TM) fund. This infusion of capital has positioned the company, which previously operated in Japan, South Korea, and recently the United States, to fortify its international expansion efforts. Additionally, the financial injection will facilitate the expansion of Polaris' sustainable production unit located in Brittany, France.

Company Products

Ultra Omega 3/6/9(TM) Softgels - NaturesPlus offers Ultra Omega 3/6/9(TM) Softgels, a dietary supplement meticulously formulated to provide optimal ratios of essential unsaturated fatty acids. Crafted from top-quality non-GMO sources, including borage oil, fish oil, and flax oil, this supplement is designed to support overall well-being by promoting heart health, maintaining strong bones, nurturing skin vitality, and supporting cognitive function.
MARNYS(R) Omega - MARNYS(R) Omega 3+6 Junior is a valuable food supplement harnessing the power of essential vegetable omega oils derived from borage and flaxseed. Borage contributes Omega-6, featuring a minimum gamma-linoleic acid (GLA) content of 20%, while Flaxseed provides Omega-3, with a minimum a-linolenic acid content of 55%. This unique combination plays a crucial role in supporting normal cardiovascular and gastrointestinal functions, as well as contributing to the maintenance of a healthy immune system. The supplement is particularly beneficial during periods of growth and organ maturation in children.
Momentous presents Omega-3 - Momentous offers its Omega-3 supplement, a formulation rich in essential fatty acids sourced from fish oil, specifically EPA and DHA. It is recommended to take 2 soft gels with food daily. Incorporating this supplement as part of your daily routine can contribute to nutritional goals.

Market Segmentation

By Application

Food
Nutraceutical
Pharmaceutical
Feed Applications

By Type

Omega-3
Omega-6

By Form

Tablet
Liquid
Softgel
Powder

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
UK
Germany
France
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
Japan
China
India
South Korea
Indonesia
Thailand
Others

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Data
2.2. Research Process

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Force Analysis
- 4.3.1. Bargaining Power of Suppliers
- 4.3.2. Bargaining Power of Buyers
- 4.3.3. Threat of New Entrants
- 4.3.4. Threat of Substitutes
- 4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. POLYUNSATURATED FATTY ACIDS MARKET BY APPLICATION

5.1. Introduction
5.2. Food
5.3. Nutraceutical
5.4. Pharmaceutical
5.5. Feed Applications

6. POLYUNSATURATED FATTY ACIDS MARKET BY TYPE

6.1. Introduction
6.2. Omega-3
6.3. Omega-6

7. POLYUNSATURATED FATTY ACIDS MARKET BY FORM

7.1. Introduction
7.2. Tablet
7.3. Liquid
7.4. Softgel
7.5. Powder

8. POLYUNSATURATED FATTY ACIDS MARKET BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. United States
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
- 8.3.3. Others
8.4. Europe
- 8.4.1. United Kingdom
- 8.4.2. Germany
- 8.4.3. France
- 8.4.4. Spain
- 8.4.5. Others
8.5. The Middle East and Africa
- 8.5.1. Saudi Arabia
- 8.5.2. UAE
- 8.5.3. Israel
- 8.5.4. Others
8.6. Asia Pacific
- 8.6.1. Japan
- 8.6.2. China
- 8.6.3. India
- 8.6.4. South Korea
- 8.6.5. Indonesia
- 8.6.6. Thailand
- 8.6.7. Others